In recent years, the legalisation of recreational marijuana has become increasingly prevalent across the United States. Since 2012, 21 states have legalised the use of marijuana for recreational purposes. However, this trend has coincided with a rise in teen mental health problems. As a psychoanalyst, I have observed a connection between the two, which has not received enough attention. Studies have shown that marijuana use in adolescence is associated with an increased risk of developing major depression, suicidality, and suicidal ideation in young adulthood. Additionally, there is a heightened risk of suicide, especially for women, associated with marijuana use.

Read more: Legal Weed Could help Feed the Teen Mental-Health Crisis

Marijuana use has become increasingly prevalent in the United States, with more states legalizing the drug for both medical and recreational purposes. However, what many people don't know is that habitual marijuana use can have a surprising side effect: users may require more anaesthesia during medical procedures to remain sedated.

Read more: What Doctors Are Learning About Marijuana and Surgery

Wall Street is increasingly investing millions of dollars in psychedelic drugs that could potentially treat mental illnesses, providing a more cost-effective alternative to current therapies. The recent capital raises by Transcend Therapeutics Inc., Gilgamesh Pharmaceuticals Inc., and Lusaris Therapeutics Inc. underscore the growing interest in the potential of these drugs. In January, Transcend Therapeutics raised $40 million from venture-capital investors to develop a post-traumatic stress disorder treatment that the company claims would require about half the amount of therapy as MDMA, a popular hallucinogen. Meanwhile, Gilgamesh Pharmaceuticals and Lusaris Therapeutics have announced capital raises of about $100 million since November for similar products addressing depression.

Read more: Wall Street Backs New Class of Psychedelic Drugs

Scotland has been grappling with a drug death epidemic for several years, with the country consistently having the highest drug death rate in Europe. However, recent data suggests that this trend may be starting to reverse.

Read more: Data Suggests Scotland's Drug Death Epidemic May Have Peaked